FTC Greenlights Barr's $2.5B Takeover Of Pliva

Law360, New York (December 11, 2006, 12:00 AM EST) -- The U.S. Federal Trade Commission has signed off on Barr Pharmaceuticals’ $2.5 billion acquisition of European generic drug giant Pliva on the condition that Barr sell the rights to four of its drug products.

On Friday, the FTC issued its final consent order, endorsing the merger along with Barr’s planned divestitures of certain overlapping product lines by a vote of 5 to 0.

The formal move comes on the heels of the Commission issuing tentative approval of the takeover in October after ordering Barr to sell...
To view the full article, register now.